MedTrace Logo

Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome

NCT03961230 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2019-05-23

No results posted yet for this study

Summary

We designed this study as a multicenter, randomized, double blinded and placebo-controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of psoriasis with blood stasis syndrome.

Conditions

  • Psoriasis Vulgaris

Interventions

DRUG

Jueyin granules

Put each bag of medicine in the same amount into the same container, pour about 50 ml of warm water, stir until the particles are basically dissolved, and then add appropriate amount of boiling water to dilute.

DRUG

Jueyin Granules Placebo

Put each bag of medicine in the same amount into the same container, pour about 50 ml of warm water, stir until the particles are basically dissolved, and then add appropriate amount of boiling water to dilute.

Sponsors & Collaborators

  • Beijing Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

    collaborator UNKNOWN

  • Gansu University of Chinese Medicine

    collaborator OTHER

  • Guangxi Zhuang Autonomous Region Dermatology Hospital

    collaborator UNKNOWN

  • Shanghai Yueyang Integrated Medicine Hospital

    lead OTHER

Principal Investigators

  • Jia Zhou · Department of dermatology, Shanghai Yueyang Integrated Medicine Hospital, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03961230 on ClinicalTrials.gov